Sepsis Prediction

by Sirona AI  · Based in United States →Sirona AI is a scalable healthcare solution that optimizes workflows delivering instant value and savings.
Critical Care Emergency Medicine Hospital Medicine

Overview

Sirona.ai offers an advanced AI-powered platform specifically designed for the early detection and prediction of sepsis. This critical tool empowers physicians in high-stakes environments like ICUs and Emergency Departments to identify at-risk patients significantly earlier, facilitating timely intervention and potentially life-saving treatment decisions.

The platform leverages real-time patient data, applying sophisticated predictive analytics to continuously monitor and assess a patient’s risk of developing sepsis. By analyzing a multitude of physiological parameters and clinical data points, Sirona.ai’s system can provide a dynamic risk score and actionable insights, moving beyond traditional scoring systems to offer a more nuanced and proactive approach to sepsis management.

For physicians, this translates into enhanced clinical decision support, allowing for a more informed and rapid response to patient deterioration. The goal is to improve patient outcomes, reduce sepsis-related mortality rates, and optimize the utilization of critical care resources. Customizable alerts ensure that relevant care teams are notified promptly when a patient’s risk escalates.

Sirona.ai’s solution is engineered for seamless integration with existing Electronic Health Record (EHR) systems, minimizing disruption to current workflows. This integration ensures that the AI-driven insights are readily accessible within the physician’s established clinical environment, supporting a more efficient and effective approach to critical care.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Early Sepsis Detection
  • Real-time Patient Monitoring
  • Predictive Analytics
  • Risk Stratification
  • Clinical Decision Support
  • Customizable Alerts
  • EHR Integration
  • Actionable Insights

Use Cases

  • Proactive Sepsis Management in ICUs
  • Early Intervention in Emergency Departments
  • Monitoring High-Risk Patients
  • Optimizing Resource Allocation
  • Reducing Sepsis-Related Mortality
  • Enhancing Clinical Workflow

What Physicians Need to Know

Evidence Base
Specific details regarding the evidence base (e.g., adherence to Surviving Sepsis Campaign guidelines, specific literature scope) for Sirona.ai's Sepsis Prediction tool are not publicly available. Generally, AI sepsis prediction models leverage machine learning algorithms trained on extensive clinical data from Electronic Health Records (EHRs), including vital signs, laboratory results, demographics, and comorbidities.
Clinical Validation Studies
Specific clinical validation studies for Sirona.ai's Sepsis Prediction tool are not publicly available. However, AI-driven sepsis prediction tools in general have undergone various validation studies, demonstrating capabilities such as predicting sepsis hours before clinical onset and outperforming traditional scoring systems like SIRS, SOFA, and qSOFA.
Alert Fatigue Management
Specific alert fatigue management strategies for Sirona.ai's Sepsis Prediction tool are not publicly available. In general, AI sepsis prediction systems aim to reduce alert fatigue through methods like dynamic thresholding, context-aware and tiered alerting, ensemble models, and explainable AI (XAI).
Override Rate Data
Specific override rate data for Sirona.ai's Sepsis Prediction tool are not publicly available. This type of data is typically proprietary and part of post-implementation analysis for AI clinical decision support tools.
Drug Interaction Checking
Information on drug interaction checking as a feature of Sirona.ai's Sepsis Prediction tool is not publicly available. Sepsis prediction tools primarily focus on early detection of sepsis, while drug interaction checking is a distinct clinical decision support function, often integrated separately or as part of broader pharmacy systems.
Guideline Update Frequency
Specific guideline update frequency for Sirona.ai's Sepsis Prediction tool is not publicly available. AI models generally require continuous monitoring and revalidation to maintain performance and adapt to evolving clinical guidelines, such as those from the Surviving Sepsis Campaign.
Clinical Workflow Integration
Specific details on Sirona.ai's Sepsis Prediction tool's integration with clinical workflows are not publicly available. Generally, AI sepsis prediction tools are designed to integrate with Electronic Health Record (EHR) systems to continuously monitor patient data in real-time and deliver alerts to clinicians.
Decision Audit Trail
Specific information on a decision audit trail for Sirona.ai's Sepsis Prediction tool is not publicly available. AI-augmented clinical decision support systems typically maintain automated, timestamped, and audit-ready records of alerts and clinician interactions to support accountability and continuous improvement.
Physician Tip

When utilizing AI-powered sepsis prediction tools, physicians should consider them as an adjunct to, not a replacement for, clinical judgment. Pay attention to the context provided by the AI, understand its input variables, and critically evaluate alerts in conjunction with the patient's full clinical picture. Be aware that while AI can detect subtle patterns and predict sepsis earlier, human oversight is crucial for confirming diagnoses and initiating appropriate, timely interventions. Provide feedback on alert accuracy and utility to help refine the system over time.

AI sepsis prediction tools are typically designed for seamless integration with existing Electronic Health Record (EHR) systems (e.g., Epic, Cerner) to leverage real-time patient data. This integration allows for continuous monitoring of vital signs, lab results, medications, and other clinical data, enabling the system to generate timely alerts and insights directly within the clinician's workflow. The goal is to streamline the detection process and facilitate early intervention without disrupting established clinical practices.

Details

Category Clinical Decision Support & Reference, Triage & ER/ICU AI
Pricing Unknown Pricing information is not publicly available, with the website indicating 'BUY NOW [COMING SOON!]'.
DeploymentCloud, on-premise
Mobile App1
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Unknown AI-estimated — unknown
Integrations
EHR Not specified
Specialties Critical Care, Emergency Medicine, Hospital Medicine, Internal Medicine

Social Proof

Customersunknown
Notable
unknown

What the Web Says

AI-powered sepsis prediction tools are emerging as a promising solution to improve early detection and reduce mortality rates. While some studies report high accuracy and significant reductions in patient deaths, concerns exist regarding methodological rigor, generalizability across diverse patient populations and healthcare settings, and the potential for false positives. The effectiveness of these tools often relies on high-quality, comprehensive datasets and careful validation in real-world clinical environments.

Overall: Mixed

Strengths

  • Earlier detection of sepsis, potentially hours before traditional methods.
  • Reduced mortality rates (e.g., 17-20% reduction in some studies).
  • Improved accuracy compared to traditional screening tools like SIRS, qSOFA, and MEWS.
  • Ability to analyze large amounts of clinical data in real-time.
  • Potential to shorten hospital stays and reduce readmission rates.
  • Can act as an immediate 'second opinion' for physicians, especially in emergency settings.

Limitations

  • Concerns about methodological flaws in some studies, including lack of train/test splits and use of synthetic datasets.
  • Potential for high false positive rates, which can lead to alarm fatigue and undermine clinician confidence.
  • Questions about generalizability and performance degradation when deployed in different hospitals or patient demographics.
  • Reliance on high-quality and comprehensive electronic health record data, which may be incomplete or inaccurate.
  • Some AI models may inadvertently rely on clinician suspicion already present in the data, rather than providing truly early detection.
  • Lack of standardized evaluation criteria and cohesive modeling benchmarks across studies.

Based on reviews from: Reddit, Johns Hopkins University, Northeastern University, Nature Medicine, npj Digital Medicine, PubMed, G2 Intelligence, Mayo Clinic Platform, Emory News, Clairyon, Smithsonian Magazine, JAMA Network Open

Last updated: 2026-08-06

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Sepsis Prediction

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Northwestern University News Center
AI Models Predict Sepsis in Children, May Enable Preemptive Care
Scientists at Northwestern University and Ann & Robert H. Lurie Children's Hospital of Chicago developed and validated AI models that accurately identify children at high risk for sepsis within 48 hours, enabling early preemptive care. The multi-center study is the first to use AI models to predict sepsis in children based on the new Phoenix Sepsis Criteria.
2025-10
Northeastern University
This AI system can diagnose sepsis with 99% accuracy before it becomes life-threatening
Researchers at Northeastern University have developed an AI tool that predicts life-threatening septic shock with 99% accuracy by using medical data from patients at home, in the ambulance, and in the emergency room. This three-stage approach significantly improves accuracy, with predictions being 99% correct when ambulance vital signs are included.
2025-10
PMC (PubMed Central)
Artificial Intelligence-Based Predictive Modeling for Early Detection of Sepsis in Hospitalized Patients: A Systematic Review and Meta-Analysis
This systematic review and meta-analysis of 52 studies found that AI-based predictive models, particularly those using machine learning and deep learning, achieved strong discrimination (AUC 0.79u20130.96) for early sepsis detection, often outperforming traditional tools. However, external validation and real-time implementation remain limited.
2025-12
CIDRAP
FDA clears first AI-based early warning system for sepsis
The FDA has cleared an AI-based sepsis detection system, the Targeted Real-Time Early Warning System, developed by Johns Hopkins University and commercialized by Bayesian Health. This system integrates electronic health records with advanced clinical AI to continuously monitor patients and flag sepsis up to 48 hours before clinical suspicion.
2026-05
Forbes
AI's Transformative Power: FDA Approves First Ever AI System to Help Identify Sepsis Early
The FDA approved the first AI-driven system for sepsis, Prenosis' Sepsis ImmunoScore, designed to predict sepsis and allow for earlier detection and intervention. This represents a significant advancement in medical technology, enhancing healthcare professionals' capabilities and potentially saving lives.
2024-04
Akin Gump
FDA Authorizes First AI-Enabled Test to Predict Sepsis
On April 5, 2024, the FDA authorized Prenosis Inc.'s Sepsis ImmunoScore device, the first AI-enabled diagnostic tool for sepsis. This device uses patient electronic health record data, lab findings, and clinical assessments to aid in risk assessment for sepsis presence or progression.
2024-04
UC San Diego Health
Study: AI Surveillance Tool Successfully Helps to Predict Sepsis, Saves Lives
A new study published in npj Digital Medicine highlights an AI algorithm, COMPOSER, developed by UC San Diego School of Medicine researchers, that monitors over 150 patient variables to detect sepsis before symptom onset, resulting in a 17% reduction in mortality.
2024-01
Mayo Clinic Platform
Using AI to Predict the Onset of Sepsis
AI-driven algorithms are being developed to predict sepsis early, with tools like Johns Hopkins University's Targeted Real-Time Early Warning System (TREWS) identifying 82% of sepsis patients early and reducing time to antibiotic orders. Other algorithms, such as SERA from Nanyang Technological University, predict sepsis onset 12 hours in advance with high accuracy.
2024-05

Videos

Product demos, reviews, and walkthroughs for Sepsis Prediction.

View all on YouTube

Frequently Asked Questions

AI-powered sepsis prediction tools generally demonstrate better predictive performance than traditional scoring systems, with reported AUROC values often exceeding 0.80. Some models have shown high sensitivity (e.g., 88%) and specificity (e.g., 85%), though performance can vary significantly across different clinical contexts and specific algorithms.
Sepsis prediction systems are typically machine learning models that integrate with EHRs to continuously monitor patient data in real-time. They analyze a wide range of inputs, including vital signs, demographics, laboratory test results, comorbidities, and sometimes even unstructured clinical notes.
Several studies suggest that implementing AI sepsis prediction algorithms can significantly improve patient outcomes, including reductions in in-hospital mortality (up to 39.5%), length of hospital stay (up to 32.3%), and 30-day readmissions. Early and accurate prediction enables timely clinical interventions, such as antibiotic administration, which is crucial for improving prognosis.
AI-driven tools generally outperform traditional screening methods like SIRS, qSOFA, and MEWS in terms of predictive accuracy and timeliness, often identifying sepsis hours before clinical recognition. While traditional tools can have high sensitivity (SIRS) or specificity (qSOFA), they often lack the comprehensive real-time analysis capabilities of AI, and qSOFA is not recommended as a single screening tool.
Common limitations include variability in model performance across different hospitals and patient populations, leading to potential site biases and inaccurate predictions. Algorithms can also exhibit biases related to race, gender, and socioeconomic factors, potentially worsening healthcare disparities if not carefully addressed. Additionally, some models may generate high false alarm rates, contributing to alert fatigue among clinicians.
Yes, sepsis prediction tools can generate both false positives and false negatives, which have significant clinical implications. High false positive rates can lead to alert fatigue, desensitizing clinicians and potentially delaying responses to true sepsis cases, while false negatives mean missed early detection opportunities, increasing morbidity and mortality. The trade-off between sensitivity and specificity is a critical consideration for practical utility.
Specific pricing information for sepsis prediction clinical decision support systems is not widely published, but these technologies are not free and represent an investment for healthcare systems. However, by enabling earlier diagnosis and intervention, these systems have the potential to reduce overall healthcare costs associated with sepsis, such as decreased length of hospital stay and lower readmission rates.

Related Tools

OCTA
OCTA
Clinical Decision Support & Reference
OCTA Flow is an AI-powered platform that assists ophthalmologists in analyzing Optical Coherence Tomography Angiography (OCTA) scans to enhance diagnostic accuracy and efficiency.
Elsevier
Elsevier
Clinical Decision Support & Reference
ClinicalKey AI is a clinical decision support tool that uses artificial intelligence to provide physicians with rapid access to evidence-based medical information.
EvidenceMD
EvidenceMD
Clinical Decision Support & Reference
EvidenceMD is an AI-powered clinical decision support platform that provides physicians with rapid access to current and relevant medical evidence for informed decision-making.
FAITH project
AI Agent
Clinical Decision Support & Reference
The FAITH project focuses on Federated Artificial Intelligence for Trusted Healthcare, aiming to develop secure and privacy-preserving AI solutions for healthcare, including potential applications for physician directories.
AI-based support system for skin cancer diagnostics
German Cancer Research Center (DKFZ)
Clinical Decision Support & Reference
Scientists at the German Cancer Research Center have developed an AI-based support system for skin cancer diagnostics that explains its decisions, increasing doctors' confidence in both the AI and their own diagnoses.
Prof. Valmed
Prof. Valmed - validated medical information GmbH
Clinical Decision Support & Reference
Prof. Valmed is Europe's first CE Class IIb certified AI-supported medical co-pilot, providing healthcare professionals with validated, evidence-based medical information through an innovative AI platform.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Last Verified: 2026-05-07 | First Added: 2026-05-07
AI Tool Finder
AI-powered search. Results may not be comprehensive.